NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Fabentech

Fabentech

Private
LyonHealthcare & Life Scienceshttps://www.fabentech.com/

Last Round

Debt

Oct 7, 2024

Total Funding Raised

$15.65M

Company Overview

Fabentech is a biopharmaceutical company that develops and produces polyclonal antibody-based immunotherapies to address high-priority biological threats and infectious diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Defense Tech, Drug Discovery

Business Model

B2G

Customer Profile

Government Contracts, Services & Consulting

AI Layer

Non-AI

Keywords

biodefensemedical countermeasurespolyclonal antibodiesimmunotherapybiosecurityB2Gpandemic preparednessdefense techbiotechbiomanufacturingF(ab')2 fragmentsemergency medicinehealth sovereigntyGMP manufacturing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Fabentech Comparables

Compare Fabentech with similar companies based on industry and business-model similarity.

Fabentech comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
PlantForm Corporation
78%
SAb Biotherapeutics
76%
Emergent Biosolutions Inc.
73%

Fabentech Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
DebtOct 7, 2024
GrantDec 9, 2021
VC RoundJan 31, 2020

Key People

Founding team and executive leadership

Dario Eklund

Chief Executive Officer

Executive Team

Ludovic NGUYEN

Chief Operating Officer, Head of Industrial Affairs

Executive Team

Fabentech Investors

Notable investors and investment history

Fabentech investors
InvestorRounds
Sigma GestionVC Round
Elaia PartnersVC Round
European CommissionGrant
KreaxiVC Round
European Investment Bank GroupDebt
BpifranceVC Round
Institut MérieuxVC Round

Fabentech Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Fabentech Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Fabentech's valuation, stock price, and market status.

Firmographic Details

HeadquartersLyon
Employee Range71
Year Founded2009
Last FundingOct 7, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.